All bets are on for biotech deals after $14B Medivation bonanza – FierceBiotech


FierceBiotech

All bets are on for biotech deals after $14B Medivation bonanza
FierceBiotech
This was good news for Medivation’s shareholders (shares for the company were $37 pre-deal speculation, but ended up over $80 yesterday), for Hung and as it turns out, much of the biotech industry given that this has reinvigorated M&A speculation
Pfizer’s Medivation Deal Latest in Long Line of Similar AcquisitionsWall Street Journal
Pfizer’s Medivation Deal May Not Be EnoughFortune
Keep me signed inInvestor’s Business Daily
The Boston Globe –Fox News
all 369 news articles »

Read More…

Share This: